Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Spamme54321on Feb 23, 2024 11:27am
111 Views
Post# 35895677

RE:RE:RE:RE:RE:yesterday's call

RE:RE:RE:RE:RE:yesterday's call
Oil you can't be serious. Were you born yesterday?
So you believe everything management tells you LOL.
MercedesLadyBoy his blind followers lower the IQ of this board.

Broken promises from management -

- Kidney Dialysis Sami and Demi were going to be game changers. Now we find out there are problems with the device

- PMX trial was going to take 15 months. This was  3 years ago and where are we now?

- 90 patient enrollment was to be a milestone. Now look at the stock price after that annoucement

- Baxter would see the data at 90 meaning also it would have to be released to the public and that did not happen

- Assume we will reach 150 by end of year. I hope its true

- There is still risk of passing FDA

- Nobody know what the true market size is until it hits the market. 2 billion is just another assumption by management
<< Previous
Bullboard Posts
Next >>